Anti-IGF2BP1 (IMP1) (Human) pAb (Polyclonal Antibody)
IGF2BP1/IMP1 Polyclonal Antibody.






Specifications:
Description
Polyclonal Antibody of 200 µl targeting IGF2BP1/IMP1 for IP, RIP, WB.
Target: | IGF2BP1/IMP1 |
---|---|
Product Type: | Antibody |
Size: | 200 μl |
Application: | IP, RIP, WB |
Research Area / Disease: | Epigenetics |
Conjugate: | Unlabeled |
Antibody Type: | Polyclonal |
Concentration: | 1 mg/mL |
Formulation: | 200 μl volume of PBS containing 50% glycerol, pH 7.2. No preservative is contained. |
Immunogen: | Peptide bond synthesis KQQHQKGQSNQAQARRK KLH (561-577 aa) |
Host Species: | Rabbit |
Species Reactivity: | Human, Mouse |
Source: | This antibody was purified from rabbit serum by affinity column chromatography. The rabbit was immunized with KLH conjugated synthetic peptide, KQQHQKGQSNQAQARRK corresponding to 561-577 aa. |
Reactivity: | This antibody reacts with human IGF2BP1 (~63 kDa) on Western blotting, Immunoprecipitation and RNP Immunoprecipitation. |
Gene ID Human: | |
Gene ID Mouse: | |
Storage Temperature: | -20°C |
Regulatory Statement: | For Research Use Only. Not for use in diagnostic procedures. |
Citations
- Conway AE et al. Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and Survival. Cell Rep. 15, 666-79,
- King DT et al. Assessing Specific Oligonucleotides and Small Molecule Antibiotics for the Ability to Inhibit the CRD-BP-CD44 RNA Interaction. PLoS One 9, e91585 (2014),
- Patel VL et al. Spatial arrangement of an RNA zipcode identifies mRNAs under post-transcriptional control. Genes Dev. 26, 43-53 (2012),
- Stoskus M et al. ETV6/RUNX1 transcript is a target of RNA-binding protein IGF2BP1 in t(12;21)(p13;q22)-positive acute lymphoblastic leukemia. Blood Cells Mol Dis. 57, 30-4 (2016)
- Enhanced CLIP Uncovers IMP Protein-RNA Targets in Human Pluripotent Stem Cells Important for Cell Adhesion and Survival.
Conway AE et al. Cell Rep. 15, 666-79 (2016)
References
- Liao, B., et al., J. Biol. Chem. 280, 18517-18524 (2005)
- Ioannidis, P., et al., Int. J. Cancer 104, 54-59 (2003)
- Nielsen, J., et al., Mol. Cell. Biol. 19, 1262-1270 (1999)